Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
about
Hepatitis C: a review for primary care physiciansAntiviral treatment for chronic hepatitis C in patients with human immunodeficiency virusAntiviral therapy for chronic hepatitis C in patients with human immunodeficiency virusContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionEffect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patientsHuman Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent VirusesImpact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treaChallenges in the treatment of HIV and HCV coinfection.Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infectionsHepatitis C virus infection in the human immunodeficiency virus infected patient.Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.Hepatitis B and hepatitis C co-infection in patients with HIV.Effects of HCV on basal and tat-induced HIV LTR activationActivation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virusDefective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV.Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.Hepatitis C and HIV-1 coinfection.Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center studyNew hopes for HIV and HCV coinfection in 2004.Parvovirus 4 infection and clinical outcome in high-risk populations.Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory.HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescentsAntiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.HIV-HCV Coinfection.Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.Hepatitis C virus replication in Caucasian HIV controllers.The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.Viral coinfections among African children infected with human immunodeficiency virus type 1.Racial difference in mortality among U.S. veterans with HCV/HIV coinfection.
P2860
Q22306040-40B18E48-5C73-4953-BFC3-043CD8655ED8Q24240929-56017334-4FB4-4370-9B94-B21E1B9E1CD8Q24246928-52448D18-B1EC-4C5D-B7CC-9D6065CB41EBQ24550678-9CFC989F-1058-45E9-92B8-36BD20106967Q27470167-51D5B8B3-5870-44C6-88EB-752075202B73Q27472844-2A92BAFE-26D6-4355-95CF-29AF19F39DE4Q27473086-ED53095B-FF4B-46F8-B791-3E831428271EQ27490328-3C9DD547-A3DB-4784-9EBD-B74AF2A1EECFQ30389282-36DC8591-F042-4638-A759-F6E27A7933EFQ33585762-ABC4E8E6-D00E-4624-8945-D15A4F2A732CQ33999381-61AA96A3-3711-4D1A-8BB6-71B697840317Q34168504-ED56F8FA-3215-472E-8ABA-334168DE151DQ34245650-81565F13-F2EB-4374-9D6D-A0CC18EFCC8FQ34323219-55923F3D-3871-48E5-B80F-3EA260B8B693Q34769530-3615BB34-A64F-4AA1-BAB8-FAD39C519786Q35018396-A085D68F-394D-4F41-96B7-DAFDF1C6A797Q35056266-83554A67-BD9B-4F55-A903-DAD4CAA26E42Q35056682-19DEC944-C91C-42A6-9A6D-64AC6D68A106Q35079621-73F2A47F-B19F-41D6-B382-6909FBD3DCF0Q35169664-C2BBC7FB-6718-4331-8B95-250A7F112820Q35595027-78C87270-5737-42C7-B094-21CDB7C51704Q35635844-A9A72337-71BA-433D-A818-EC68F1F85715Q35793055-F66A497D-4C60-4370-9E44-BADA8455FF43Q35912407-D3FFE165-677E-4CBE-A3AC-75545DAEA3ACQ35975989-4D5683C1-81A6-4A49-8A35-C03EBACBA239Q36119738-77C4B567-6D14-4CCE-A1E6-018FC3034484Q36479368-40CFE1CB-AF69-4488-B454-EB29356673A3Q36542411-3D517502-627B-4D33-8759-13094469877EQ36698602-8DD6770A-5F37-4553-B6BE-32FEFCEB26DBQ37513556-0557F9C1-77D3-40E6-84F8-64AE482EF25BQ38900456-08B011CE-E8B6-4057-A54A-39C8D338EA2CQ41040128-6FFD75A1-511C-468F-8688-FF6D3A270A90Q41878055-E68A798B-E5AB-4A46-969A-AAE64B0238A5Q42318165-4598ED88-CC4C-4B05-BD65-0FCDD786D12AQ42992579-631DD958-5E67-472B-9712-10955592F801Q43037903-4549E440-A847-443E-8B38-EC9DC55CFA66Q43040318-DD539CAA-3C22-4CB0-87D8-F4529A79932CQ43048607-31A57F11-1516-4B88-B629-7174E3F6BDE5Q43049174-DB3CC8CB-554D-411D-8082-D08B6D6FE220Q45332840-46486654-C851-47D6-8306-C35BF204D773
P2860
Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@en
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@nl
type
label
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@en
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@nl
prefLabel
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@en
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@nl
P2093
P356
P1476
Hepatitis C virus load is asso ...... e progression in hemophiliacs.
@en
P2093
C A Winkler
D Chernoff
E Gomperts
Hemophilia Growth and Development Study
M W Hilgartner
S Donfield
S J O'Brien
P304
P356
10.1086/318539
P407
P577
2001-01-12T00:00:00Z